Assembly Biosciences (ASMB) Income from Continuing Operations (2016 - 2025)
Historic Income from Continuing Operations for Assembly Biosciences (ASMB) over the last 9 years, with Q3 2025 value amounting to -$9.2 million.
- Assembly Biosciences' Income from Continuing Operations rose 433.79% to -$9.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$38.5 million, marking a year-over-year increase of 553.13%. This contributed to the annual value of -$40.2 million for FY2024, which is 3438.13% up from last year.
- According to the latest figures from Q3 2025, Assembly Biosciences' Income from Continuing Operations is -$9.2 million, which was up 433.79% from -$10.2 million recorded in Q2 2025.
- Assembly Biosciences' 5-year Income from Continuing Operations high stood at -$8.8 million for Q1 2025, and its period low was -$62.8 million during Q4 2021.
- In the last 4 years, Assembly Biosciences' Income from Continuing Operations had a median value of -$11.2 million in 2024 and averaged -$17.5 million.
- Per our database at Business Quant, Assembly Biosciences' Income from Continuing Operations crashed by 46145.12% in 2021 and then skyrocketed by 5210.03% in 2024.
- Over the past 4 years, Assembly Biosciences' Income from Continuing Operations (Quarter) stood at -$62.8 million in 2021, then skyrocketed by 82.54% to -$11.0 million in 2023, then grew by 5.72% to -$10.3 million in 2024, then increased by 11.02% to -$9.2 million in 2025.
- Its last three reported values are -$9.2 million in Q3 2025, -$10.2 million for Q2 2025, and -$8.8 million during Q1 2025.